• Our recent editorial in the Journal presents an accurate summary of our two randomised trials of vertebroplasty, which found no benefit of vertebroplasty over placebo. • Participants in both trials are representative of patients seen in clinical practice and who would qualify for government-subsidised funding of vertebroplasty in Australia. • Clinical experience and previous published literature are likely to have overestimated the treatment benefit of vertebroplasty for many reasons. • This is why randomised placebo-controlled trials are required to determine the efficacy of treatment interventions, particularly when the condition being treated is self-limiting and the primary end point is improvement of symptoms. • Based on the best evidence currently available, the routine use of vertebroplasty outside of the research setting for painful osteoporotic vertebral fractures appears unjustified.
|Original language||English (US)|
|Number of pages||4|
|Journal||Medical Journal of Australia|
|State||Published - Mar 15 2010|
ASJC Scopus subject areas